SWHR responded to the National Heart, Lung, and Blood Institute (NHLBI) Women’s Health Working Group (WHWG) request for information regarding […]
SWHR released a letter of support sent to both Sen. Tammy Duckworth (D-IL) and Rep. Jan Schakowsky (D-IL-09) in acknowledgment […]
In comments to the Food and Drug Administration (FDA) on its Patient-Focused Drug Development (PFDD) Program, SWHR encouraged inclusion of the […]
SWHR sent a letter to Centers for Medicare & Medicaid Services (CMS) Administrator Seema Verma expressing concerns regarding a recent […]
SWHR submitted comments to the federal Food and Drug Administration (FDA) regarding FDA’s recently issued draft guidance on recommendations for the […]
SWHR signed on to a coalition letter to Senators Lamar Alexander (R-TN) and Patty Murray (D-WA), as well as to […]
In comments to the Institute for Clinical and Economic Review (ICER), SWHR recommended the organization delay finalizing its draft evidence […]
Together with a committee of stakeholder organizations, SWHR sent a letter to congressional committee leadership urging Congress to reform the […]
SWHR submitted comments to the Institute for Clinical and Economic Review (ICER) on ICER’s new draft report regarding the effectiveness […]
SWHR issued comments to the federal Food and Drug Administration (FDA) regarding its recent workshop on methodological approaches for collecting […]